Large-scale testing (Phase 3)Study completedNCT02329327
What this trial is testing
A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)
Who this might be right for
Bleeding
Alexion Pharmaceuticals, Inc. 479